venetoclax,ivosidenib,azacitidine
servier,roche,abbvie
['ivosidenib', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'triplet']
3) triplet of ivosidenib+venetoclax +/- azacitidine seems to be a promising combination in idh1 mutated #aml #asco22
Hematologist. Leukemia, clonal hematopoiesis and epigenetics.